News | March 14, 2023
Briefs: Lupin and Alembic
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
The company will be submitting the responses to US FDA observations within stipulated timeline
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
he product will be launched shortly in the US market.
Subscribe To Our Newsletter & Stay Updated
